Cargando…
A systematic review of the research progress of traditional Chinese medicine against pulmonary fibrosis: from a pharmacological perspective
Pulmonary fibrosis is a chronic progressive interstitial lung disease caused by a variety of etiologies. The disease can eventually lead to irreversible damage to the lung tissue structure, severely affecting respiratory function and posing a serious threat to human health. Currently, glucocorticoid...
Autores principales: | Qin, Shanbo, Tan, Peng, Xie, Junjie, Zhou, Yongfeng, Zhao, Junning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398979/ https://www.ncbi.nlm.nih.gov/pubmed/37537605 http://dx.doi.org/10.1186/s13020-023-00797-7 |
Ejemplares similares
-
Research Progress of Traditional Chinese Medicine in Treatment of Myocardial fibrosis
por: Ren, Chunzhen, et al.
Publicado: (2022) -
Traditional Chinese medicine for pulmonary fibrosis therapy: Progress and future prospects
por: Li, Liu-Cheng, et al.
Publicado: (2017) -
Molecular mechanism and research progress on pharmacology of traditional Chinese medicine in liver injury
por: Zhang, Hong Yang, et al.
Publicado: (2018) -
Applications of Network Pharmacology in Traditional Chinese Medicine Research
por: Zhou, Zhuchen, et al.
Publicado: (2020) -
Network Pharmacology in Traditional Chinese Medicine
por: Li, Shao, et al.
Publicado: (2014)